Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lik Sprava ; (3-4): 26-30, 2014.
Artigo em Ucraniano | MEDLINE | ID: mdl-25286594

RESUMO

Allergic diseases are among the most popular in the world. Scientific hypothesis formation and multifactorial pathogenesis of atopic asthma (AA) is constantly updated. Our purpose of this study was to investigate the relationship of humoral and cellular immunity with features clinical and anamnestic data in patients AA. Found that AA is genetically determined disorders, mainly transmitted through the maternal line, characterized polisensibilization, most of household allergens. AA is often associated with other allergic nosology (62.2%) and gastrointestinal diseases (44.4%). In the absence of clinical evidence of disease at CD4+/CD25+/Foxp3+, IgE and IL-4 in patients with AA is higher than in healthy individuals. When polyvalent allergy has been a significant increase in IgE (199.3 +/- 22.2) and IL-4 (79.2 +/- 16.5) and reduced expression of molecules CD4+/CD25+/Foxp3+ compared with sensitization to one or two allergens.


Assuntos
Alérgenos/imunologia , Asma/patologia , Imunoglobulina E/imunologia , Linfócitos T Reguladores/patologia , Adolescente , Adulto , Idoso , Alérgenos/classificação , Alérgenos/genética , Asma/genética , Asma/imunologia , Antígenos CD4/genética , Antígenos CD4/imunologia , Feminino , Fatores de Transcrição Forkhead/genética , Fatores de Transcrição Forkhead/imunologia , Regulação da Expressão Gênica , Humanos , Imunidade Celular , Imunidade Humoral , Imunoglobulina E/genética , Subunidade alfa de Receptor de Interleucina-2/genética , Subunidade alfa de Receptor de Interleucina-2/imunologia , Interleucina-4/genética , Interleucina-4/imunologia , Masculino , Pessoa de Meia-Idade , Linfócitos T Reguladores/imunologia
2.
Lik Sprava ; (1-2): 15-20, 2014.
Artigo em Ucraniano | MEDLINE | ID: mdl-24908954

RESUMO

In research the condition cellular and humoral immunity is defined at allergic rhinitis--AR (n = 45) for an estimation of mechanisms pathogeny this disease. The AR in 76% of cases has the hereditary nature mainly from outside mothers (36%), begins more often at children's and teenage age (88%) and in 44% is accompanied by other allergic pathology. In structure of a sensibilization of patients the allergic rhinitis the basic place is occupied with pollen, household, fungoid and epidermal allergens, allergic reaction (83% of cases) thus prevailed. As a result of the spent researches rising of relative quantity CD4+CD25+Foxp3+ regulatory T cells is taped, at the same time rising of an average level of the general IgE--(198,20 +/- 11,42) IU/ml is noted. In cytokine regulations at patients an allergic rhinitis rising IL-4 and depression IL-10 is noted. Thus, the conducted research suggests that an allergic rhinitis--disease with involving in process of regulation of the immune answer of certain type regulatory T of cells.


Assuntos
Imunidade Celular , Imunidade Humoral , Rinite Alérgica Perene/imunologia , Adulto , Idoso , Antígenos CD4/sangue , Linfócitos T CD4-Positivos/imunologia , Feminino , Fatores de Transcrição Forkhead/sangue , Humanos , Imunoglobulina E/sangue , Subunidade alfa de Receptor de Interleucina-2/sangue , Contagem de Linfócitos , Masculino , Pessoa de Meia-Idade , Rinite Alérgica , Rinite Alérgica Perene/sangue , Linfócitos T Reguladores/imunologia , Adulto Jovem
3.
Lik Sprava ; (1): 109-17, 2013.
Artigo em Ucraniano | MEDLINE | ID: mdl-23951921

RESUMO

6 monthly application of the combination of metformin with ramipril (1000 and 5 mg per day respectively) in complex treatment of metabolic syndrome (MS) leads to improvement of the clinical course of ischemic heart disease (decrease of quantity and duration of painful cardial attacks, depression of the functional class of an angina of exertion, decrease of displays of chronic heart failure), normalization of arterial pressure and decrease of an abdominal obesity which can be considered as prophylaxis of development of diabetes mellitus 2 types and its cardiovascular complications. Combination of metformin with ramipril in complex treatment of a MS is effective and safe option of therapy of MS.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Diabetes Mellitus Tipo 2/tratamento farmacológico , Síndrome Metabólica/tratamento farmacológico , Metformina/uso terapêutico , Ramipril/uso terapêutico , Idoso , Glicemia/análise , Pressão Sanguínea/efeitos dos fármacos , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/epidemiologia , Quimioterapia Combinada , Humanos , Síndrome Metabólica/complicações , Síndrome Metabólica/epidemiologia , Metformina/administração & dosagem , Pessoa de Meia-Idade , Ramipril/administração & dosagem , Resultado do Tratamento
4.
Lik Sprava ; (3): 93-6, 2013.
Artigo em Ucraniano | MEDLINE | ID: mdl-25016756

RESUMO

Expression of clusters determination of T-cells immune links (CD4, CD8, CD95) and level of interferon-alpha at newborns with multiorgan failure syndrome were investigated. It were shown supressive character of immune reactions and reduction the level of interferon-alpha in this contingent of patients.


Assuntos
Antígenos CD4/biossíntese , Antígenos CD8/biossíntese , Insuficiência de Múltiplos Órgãos/etiologia , Insuficiência de Múltiplos Órgãos/imunologia , Linfócitos T/imunologia , Receptor fas/biossíntese , Biomarcadores/análise , Antígenos CD4/sangue , Antígenos CD8/sangue , Citometria de Fluxo , Humanos , Recém-Nascido , Receptor fas/sangue
5.
Fiziol Zh (1994) ; 58(3): 19-26, 2012.
Artigo em Ucraniano | MEDLINE | ID: mdl-22946309

RESUMO

The aim of this study was to assess the influence of fullerene C60 on lipid peroxidation (POL) and antioxidant protection during the induction of the immune response to heteroantigen. Balb/c mice were immunized intraperitoneal (i.p.) with sheep erythrocytes for the primary immunization. Water dispersion of fullerene C60 was injected i.p. once at the dose 50 ng to mice on first, third and sixth days after immunization. During immune response, the increment ofmalonic dialdehide (MDA) was enhanced in liver, kidneys and heart tissues. Fullerene C60 induced POL during the latent phase of immune response, but inhibited this process during progression of immune response. Activities of superoxide dismutase (SOD) and catalase in liver and spleen tissues were induced after injection of fullerene C60 to intact mice. After immunization, high level of activity of antioxidant enzymes and low level of organs mass factor were determined. Injection of fullerene C60 reduced the activities of SOD and catalase in spleen tissues. The results of our study indicate that fullerene C60 can display positive effect on POL processes and antioxidant enzymes activity which is probably due to membrane's stabilization action or the ability of fullerene C60 to bind free radicals independently.


Assuntos
Antígenos Heterófilos/imunologia , Antioxidantes/uso terapêutico , Eritrócitos/imunologia , Fulerenos/uso terapêutico , Peroxidação de Lipídeos/efeitos dos fármacos , Animais , Antígenos Heterófilos/administração & dosagem , Antioxidantes/administração & dosagem , Catalase/metabolismo , Radicais Livres/antagonistas & inibidores , Radicais Livres/metabolismo , Fulerenos/administração & dosagem , Coração/efeitos dos fármacos , Injeções Intraperitoneais , Rim/efeitos dos fármacos , Rim/imunologia , Rim/metabolismo , Peroxidação de Lipídeos/imunologia , Fígado/efeitos dos fármacos , Fígado/imunologia , Fígado/metabolismo , Masculino , Malondialdeído/análise , Camundongos , Camundongos Endogâmicos BALB C , Ovinos , Baço/efeitos dos fármacos , Baço/imunologia , Baço/metabolismo , Superóxido Dismutase/metabolismo
6.
Fiziol Zh (1994) ; 58(2): 33-8, 2012.
Artigo em Ucraniano | MEDLINE | ID: mdl-22873050

RESUMO

In order to examine the impact of PPAR-gamma activator on the expression of kB nuclear transcription factor and apoptosis, the peripheral blood mononuclear cells (PBMC) were incubated with pioglitazone at concentrations 10, 30 and 100 MM. Expression of NF-kB in CD64+ cells was evaluated by flow cytometry using monoclonal antibodies. The development of apoptosis was evaluated using annexin V and propidium iodide. Activation of PPAR-y resulted in a reduction of the number of CD64+ cells and expression of the maximum levels of these receptors. We also obesrved a dose-dependent decrease of NF-kB concentration in PBMC suspension and in CD64+ cells. While analyzing the apoptosis, the reduction of apoptotic cells (reduction of AnV+PI+ cells) has been observed. The results obtained allow to prove that PPAR-gamma activation participates in the PBMC apoptosis regulation and in the expression of transcriptional factor NF-kB. Our results indicate for the involvement of PPAR-gamma in the regulation of NF-kB activity which plays one of the most significant roles in the inflammation realization, oncogenesis, and so on.


Assuntos
Hipoglicemiantes/farmacologia , Leucócitos Mononucleares/efeitos dos fármacos , NF-kappa B/antagonistas & inibidores , PPAR gama/agonistas , Tiazolidinedionas/farmacologia , Adulto , Anexina A5 , Apoptose/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Feminino , Citometria de Fluxo , Expressão Gênica/efeitos dos fármacos , Humanos , Leucócitos Mononucleares/citologia , Leucócitos Mononucleares/metabolismo , NF-kappa B/genética , PPAR gama/genética , Pioglitazona , Propídio , Receptores de IgG/biossíntese
7.
Tsitol Genet ; 46(6): 59-66, 2012.
Artigo em Russo | MEDLINE | ID: mdl-23285751

RESUMO

The aim of the research was to identify the role of genes polymorphisms encoding TLR2 (NP_003255.2) and TLR4 (NP_612564.1) in the increase of the specific IgE production level and development of allergic diseases. Genetic typing of genome specific regions was performed by polymerase chain reaction method using specific oligonucleotide primers. The obtained results display that the most significant causative allergens are epidermal and household allergens (epidermis of cat, dog and horse, D. farinae, D. pteronyssinus). The relationship of polymorphisms TLR2 (rs5743708) and TLR4 (rs4986790) with increased production of specific IgE in patients with allergic diseases was also observed.


Assuntos
Hipersensibilidade/genética , Imunoglobulina E/sangue , Polimorfismo de Nucleotídeo Único , Receptor 2 Toll-Like/genética , Receptor 4 Toll-Like/genética , Alérgenos/imunologia , Estudos de Casos e Controles , Interpretação Estatística de Dados , Frequência do Gene , Predisposição Genética para Doença , Genótipo , Humanos , Hipersensibilidade/imunologia , Reação em Cadeia da Polimerase
8.
Klin Lab Diagn ; (7): 20-3, 2011 Jul.
Artigo em Russo | MEDLINE | ID: mdl-21899113

RESUMO

The purpose of study was to develop and test the method of determination of destruction of endotheliocytes in blood-vascular system. The level of circulating endothelial cells was determined by enumeration of CD32+CD40+ micro particles by means of flow cytofluorometry. During the application of the modified method it is demonstrated that in patients with metabolic syndrome the amount of CD32+CD40+ micro particles is twice higher than in the control group (p < 0.05). The research data revealed the increase of content of big endothelin and atherogenic lipoproteids. The method of determination of the level of circulating CD32+CD40+ micro particles can be applied to assess the desquamationed endotheliocytes.


Assuntos
Antígenos CD40/sangue , Micropartículas Derivadas de Células/metabolismo , Células Endoteliais/metabolismo , Receptores de IgG/sangue , Idoso , Células Endoteliais/imunologia , Endotelina-1/sangue , Endotélio Vascular/citologia , Endotélio Vascular/fisiopatologia , Citometria de Fluxo/métodos , Humanos , Masculino , Síndrome Metabólica/patologia , Pessoa de Meia-Idade
9.
Eksp Klin Farmakol ; 74(6): 26-9, 2011.
Artigo em Russo | MEDLINE | ID: mdl-21870772

RESUMO

The effect of aqueous dispersion of fullerene C60 (FC60) on the functional activity of cells involved in the phagocytosis reactions was studied. FC60 (0.01 microM/l and 0.1 microM/l) produced mainly negative effects on the activity ofnonspecific immunity cells by inhibiting the myeloperoxidase enzymatic activity, decreased the level of induced chemiluminescence, and suppressed the expression of molecules CD54 involved in the adhesion. The only exception was a slight stimulating effect on the NBT test. The results indicate the FC60 influences various stages and mechanisms of phagocytosis.


Assuntos
Fulerenos/efeitos adversos , Molécula 1 de Adesão Intercelular , Neutrófilos/efeitos dos fármacos , Peroxidase/antagonistas & inibidores , Fagocitose/efeitos dos fármacos , Adulto , Adesão Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Feminino , Humanos , Molécula 1 de Adesão Intercelular/sangue , Molécula 1 de Adesão Intercelular/efeitos dos fármacos , Luminescência , Linfócitos/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Monócitos/efeitos dos fármacos
10.
Lik Sprava ; (3-4): 71-8, 2011.
Artigo em Russo | MEDLINE | ID: mdl-22416367

RESUMO

We investigated the effectiveness of pioglitazone in the treatment of patients with coronary heart disease in combination with MS. In the conduct of research revealed that the addition to standard therapy in patients with coronary heart disease on the background of metabolic syndrome pioglitazone led to a reliable slight decrease in body weight, BMI, hip circumference, waist their relationship. Receiving pioglitazone also significantly reduces the concentration of immunoreactive insulin and blood glucose levels, significantly altered lipid metabolism, which generally leads to a lower level of systemic inflammation, metabolism and reduces the severity of insulin resistance. This allows you to recommend the inclusion of pioglitazone in complex coronary heart disease and metabolic syndrome.


Assuntos
Doença das Coronárias/tratamento farmacológico , Hipoglicemiantes/administração & dosagem , Síndrome Metabólica/tratamento farmacológico , Tiazolidinedionas/administração & dosagem , Idoso , Anlodipino/administração & dosagem , Anlodipino/uso terapêutico , Aspirina/administração & dosagem , Aspirina/uso terapêutico , Atorvastatina , Bisoprolol/administração & dosagem , Bisoprolol/uso terapêutico , Glicemia/análise , Índice de Massa Corporal , Peso Corporal/efeitos dos fármacos , Proteína C-Reativa/análise , Proteína C-Reativa/imunologia , Doença das Coronárias/sangue , Doença das Coronárias/complicações , Doença das Coronárias/imunologia , Doença das Coronárias/fisiopatologia , Ácidos Heptanoicos/administração & dosagem , Ácidos Heptanoicos/uso terapêutico , Humanos , Hipoglicemiantes/uso terapêutico , Insulina/sangue , Resistência à Insulina , Dinitrato de Isossorbida/administração & dosagem , Dinitrato de Isossorbida/uso terapêutico , Metabolismo dos Lipídeos/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Síndrome Metabólica/sangue , Síndrome Metabólica/complicações , Síndrome Metabólica/imunologia , Síndrome Metabólica/fisiopatologia , Pessoa de Meia-Idade , Pioglitazona , Pirróis/administração & dosagem , Pirróis/uso terapêutico , Tiazolidinedionas/uso terapêutico , Relação Cintura-Quadril
11.
Lik Sprava ; (7-8): 77-84, 2010.
Artigo em Ucraniano | MEDLINE | ID: mdl-21714292

RESUMO

We have studied efficiency of a complex therapy with metformin and ramipril combination (1000 mg and 5 mg per day) respectively in patients with metabolic syndrome (MS). The group of patients with MS which answered the basic criteria IDF (2005) was determined. Carbohydrate and Lipidic metabolism were studied. Patients were characterized with raised weight index (WI), arterial hypertension, increased concentration of triglycerides in blood serum, of glucose, of HbAlc level and S-peptide, and also high level of endotelin (1-38) and CD32+CD40+circulating particles of endothelium. Three months treatment lead to decrease in WI, arterial pressure, triglycerides concentration, HbAlc, glucose, except CD32+CD40+. Six months treatment lead to more expressed positive dynamics. Thus, metformin and ramipril combination in patients with MS leads to decrease in insulin resistancy, carbohydrate and lipid metabolism normalization, to restoration of endothelium functions that is possible to consider as prophylaxis of the development of type 2 diabetes melitus and its cardiovascular complications.


Assuntos
Anti-Hipertensivos/uso terapêutico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Síndrome Metabólica/tratamento farmacológico , Metformina/uso terapêutico , Ramipril/uso terapêutico , Idoso , Anti-Hipertensivos/administração & dosagem , Pressão Sanguínea/efeitos dos fármacos , Índice de Massa Corporal , Metabolismo dos Carboidratos/efeitos dos fármacos , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/metabolismo , Esquema de Medicação , Quimioterapia Combinada , Humanos , Hipoglicemiantes/administração & dosagem , Metabolismo dos Lipídeos/efeitos dos fármacos , Masculino , Síndrome Metabólica/sangue , Síndrome Metabólica/metabolismo , Metformina/administração & dosagem , Pessoa de Meia-Idade , Ramipril/administração & dosagem , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...